Cargando…
Sheng-Mai-Yin inhibits doxorubicin-induced ferroptosis and cardiotoxicity through regulation of Hmox1
Doxorubicin (DOX) is a potent chemotherapeutic drug used for treating various cancers. However, its clinical use is limited due to its severe cardiotoxicity, which often results in high mortality rates. Sheng-Mai-Yin (SMY), a Traditional Chinese medicine (TCM) prescription, has been reported to exer...
Autores principales: | Meng, Peina, Chen, Zhaoyang, Sun, Tianhui, Wu, Lili, Wang, Yifan, Guo, Tianwei, Yang, Jin, Zhu, Jiebin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599746/ https://www.ncbi.nlm.nih.gov/pubmed/37770231 http://dx.doi.org/10.18632/aging.205062 |
Ejemplares similares
-
Protective effect of Sheng-Mai Yin, a traditional Chinese preparation, against doxorubicin-induced cardiac toxicity in rats
por: Ma, Shaojun, et al.
Publicado: (2016) -
The Protective Effect of Sheng Mai Yin on Diabetic Cardiomyopathy via NLRP3/Caspase-1 Pathway
por: Li, Jing-Ya, et al.
Publicado: (2022) -
ShengMai-San Attenuates Cardiac Remodeling in Diabetic Rats by Inhibiting NOX-Mediated Oxidative Stress
por: Lu, Yanting, et al.
Publicado: (2021) -
WGX50 mitigates doxorubicin-induced cardiotoxicity through inhibition of mitochondrial ROS and ferroptosis
por: Tai, Panpan, et al.
Publicado: (2023) -
Mechanism of new optimized Sheng-Mai-San Formula to regulate cardiomyocyte apoptosis through NMDAR pathway
por: Hou, Yazhu, et al.
Publicado: (2023)